- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Stiolto Respimat
Total 127 results
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveGermany, Italy, Switzerland, South Africa
-
Pearl Therapeutics, Inc.Completed
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Brazil, China, Guatemala, India, Japan, Latvia, Mexico, Peru, Poland, Russian Federation
-
Laboratoire de la MerUnknownCystic Fibrosis | Chronic RhinosinusitisFrance
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveCanada, United States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Brazil, China, Colombia, Germany, India, Japan, Mexico, Peru, Poland, Romania
-
University of British ColumbiaNot yet recruitingCerebrovascular Regulation
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic Obstructive
-
Maastricht University Medical CenterAstraZeneca; Center for Integrated Rehabilitation and Organ Failure HornUnknownChronic Obstructive Airway DiseaseNetherlands
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
3MQuotient ClinicalCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Brazil, Canada, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italy, Korea, Republic of, Lithuania, Malaysia, Mexico, Netherlands, Norway, Portugal, Singapore, Slovakia, South... and more
-
3MCompleted
-
University of SaskatchewanCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveChina
-
Verona Pharma plcCompletedCOPDUnited States, United Kingdom
-
3MSimbec ResearchCompleted
-
3MQuotient ClinicalCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Fundacio Privada Mon Clinic BarcelonaGlaxoSmithKlineRecruiting
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Denmark, Germany, Hungary, Netherlands
-
Irmandade Santa Casa de Misericórdia de Porto AlegreNovartisCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Boehringer IngelheimCompleted
-
University of CreteCompletedChronic Obstructive Pulmonary Disease
-
Helsinki University Central HospitalCompleted
-
Novartis PharmaceuticalsWithdrawnPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
University of SaskatchewanCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Netherlands
-
University of SaskatchewanCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Guatemala, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian... and more
-
Duke UniversityWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Imperial College LondonBoehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveKorea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Austria, Canada, Germany, Netherlands, Russian Federation, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Germany, Italy, New Zealand